“Postherpetic Neuralgia Pipeline Insight, 2020” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Postherpetic Neuralgia market. A detailed picture of the Postherpetic Neuralgia pipeline landscape is provided, which includes the disease overview and Postherpetic Neuralgia treatment guidelines.
The assessment part of the report embraces in-depth Postherpetic Neuralgia commercial assessment and clinical assessment of the Postherpetic Neuralgia pipeline products from the pre-clinical developmental phase to the marketed phase. In the report, a detailed description of the drug is proffered including mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Postherpetic Neuralgia collaborations, licensing, mergers and acquisition, funding, designations, and other product-related details.
Request for sample pages: https://www.delveinsight.com/sample-request/postherpetic-neuralgia-pipeline-insight
The launch of the emerging therapies is expected to significantly impact Postherpetic Neuralgia treatment scenario in the upcoming years:-
Drugs covered
1. LAT8881
2. EMA401
3. TV-45070
And many others
The key players in Postherpetic Neuralgia market are:
1. Lateral Pharma
2. Novartis Pharmaceuticals
3. Teva Pharmaceutical
And many others
Table of contents:
1. Report Introduction
2. Executive Summary
3. SWOT Analysis
4. Postherpetic Neuralgia Market Overview at a Glance
5. Postherpetic Neuralgia Disease Background and Overview
6. Postherpetic Neuralgia Epidemiology and Patient Population
7. Postherpetic Neuralgia Country-Wise Epidemiology
7.1. United States
7.2. EU-5
7.2.1. Germany
7.2.2. France
7.2.3. Italy
7.2.4. Spain
7.2.5. United Kingdom
7.3. Japan
7. Postherpetic Neuralgia Treatment & Medical Practices
8. Postherpetic Neuralgia Marketed Drug
8.1. HORIZANT: GlaxoSmithKline
9. Postherpetic Neuralgia Emerging Therapies
9.1. Key Cross Competition
9.2. LAT8881: Lateral Pharma
9.3. EMA401: Novartis Pharmaceuticals
9.4. TV-45070: Teva Pharmaceutical
12. Attribute Analysis
13. Postherpetic Neuralgia Market Size
14. 7MM Postherpetic Neuralgia : Country-Wise Market Analysis
14.1. United States
14.2. Germany
14.3. France
14.4. Italy
14.5. Spain
14.6. United Kingdom
14.7. Japan
15. Market Access and Reimbursement
16. Market Drivers
17. Market Barriers
18. Appendix
19. Postherpetic Neuralgia Report Methodology
20. DelveInsight Capabilities
21. Disclaimer
22. About DelveInsight
About DelveInsight:
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/